COVID-19 commodity in children
In Singapore, older children with COVID-19 were asymptomatic or had similar upper respiratory tract infection symptoms such as fever, sore throat, watery eyes, and dry cough; some lost smell and taste.
There is a small chance that children in other countries, such as the UK and the US, have required intensive care due to complications from COVID-19 or a non-age multisystem complaint (MIS). -C) – a multisystem inflammatory pattern involving the skin, mucous membranes similar to the mouth and eyes, gastrointestinal tract, and cardiovascular organs. Although MIS-C has not been reported in Singaporean children, the condition has been reported in Asian countries such as Korea, India, and Pakistan. Iverheal 6 and Iverheal 12 are used for covid.
Benefits of getting vaccinated against COVID-19 for children
Although younger children have become sicker with COVID-19 than adults, children can become seriously ill from complications of COVID-19 and related long-term health problems, especially children with background disease.
The COVID-19 vaccine is effective in preventing children from contracting COVID-19 and is effective against currently recognized infectious variants. therefore, getting vaccinated against COVID-19 can help prevent children from becoming infected and suffering the consequences of the complaint. It can also help prevent children from getting very sick if they are newly infected with COVID-19.
A vaccinated child is less likely to pass the disease on to others, especially more vulnerable people, for example. the elderly and those with weakened vulnerable systems. Vaccinations can give parents and children the extra reassurance they need to get back to the right conditions like live training and shared sports.
Overall, the known and implied benefits of COVID-19 vaccination outweigh the known and implied pitfalls of vaccination. Is it safe to give children the COVID-19 vaccine?
As of May 31, 2021, actual data from more than six million childhood immunizations in the United States shows that the vaccine is safe for children.
Existing vaccines that have been approved for use in adolescents have been rigorously tested to ensure they are truly safe for those 12 years of age and older during the monitoring trial period. From their use to date, there have been no reports of adverse effects affecting their development or causing endless harm to their cognition, reproduction, or other health.
All certified vaccines have been assessed to be safe at the population level, within the available monitoring timelines both during testing and post-licensing. Currently, no COVID-19 vaccine, either an mRNA vaccine or a vaccine that destroys the infecting virus, protein, or subunit, has long-term safety data. Available understanding of the natural mechanisms underpinning mRNA vaccines suggests that they shouldn’t increase the threat of the child developing any experimental, internal, or fertility issues.
Eligibility criteria for COVID-19 vaccination in children
Children with the following are presently not eligible for the COVID-19 vaccination
For the prevailing eligibility criteria, please relate to the Ministry of Health’s website then. ( streamlined on Monday, 4 July 2022)
Beginning medical conditions
For children with underpinning medical conditions and those entering chemotherapy for cancer, there should be an informed discussion with their croaker/pediatrician of the pitfalls and benefits grounded on their situation, and a common decision previous to entering the vaccination.
History of severe antipathetic responses
Children with a history of severe antipathetic responses to anaphylaxis to other vaccines should be appertained to the allergist, before taking the COVID-19 vaccine. Those with a history of antipathetic responses including anaphylaxis to food, medicines, and nonentity stings can still admit the vaccine.
light and immuno- compromised
light children and those with weakened vulnerable systems, either from illness or drug, may still admit the mRNA vaccine because it isn’t a live vaccine( i.e. a vaccine that uses a weakened form of an origin to prompt a vulnerable response). reactions/by-products after a COVID-19 vaccine
The Pfizer-BioNTech clinical trial to evaluate the safety and efficacy of the Pfizer-BioNTech vaccine for children aged 12 to 15 years, found that adolescents had a similar response to the vaccine response of young adults (progressing from 16 to 15 years of age). 25 times).
Reactions after receiving the COVID-19 vaccine, including fever, fatigue, headache, muscle aches, and pain at the injection site, usually resolve on their own within a few days. The reactions were due to a strong vulnerability response, suggesting that children make good antibodies to protect themselves.
Serious adverse reactions to the COVID-19 vaccine are very rare. To control the risk of adverse reactions, vaccine donors are covered for 30 injections post-injection.
Planned immunizations for children
Parents do not need to postpone the immunization schedule for their children due to the current COVID-19 epidemic situation, as children can still contract infectious diseases similar to measles and also harm their health.
Children who have had a designated vaccine (e.g., deadly HPV/papillomavirus) can be vaccinated against COVID-19, as long as there is a two-week gap between this vaccination.
If subsequent vaccinations are likely to be missed, it is not necessary to re-vaccinate the child with the previously registered immunizations. The vaccination schedule can be active from the time it is introduced as long as the minimum interval between vaccinations continues to be observed.